In Vivo Toxicological Evaluation Service for Veterinary (Pet) Antibody

In vivo toxicological evaluation for veterinary therapeutic antibodies: Ensuring the safety and efficacy of your next-generation pet therapeutics. Are you currently facing the complexities of assessing the safety profile of novel antibody drugs in companion animals, navigating intricate regulatory requirements, and managing demanding in vivo studies? Creative Biolabs' specialized in vivo toxicological evaluation service helps you confidently de-risk your antibody candidates and generate robust safety data. We achieve this through the use of target-relevant animal models, study designs compliant with state-of-the-art bioanalytical methods.

Introduction

Creative Biolabs translates your promising therapeutic antibody from a lab concept into a de-risked candidate ready for pivotal studies. Our core objective is to provide a comprehensive safety assessment that satisfies global regulatory expectations for veterinary medicine. We deliver a clear understanding of your antibody's in-life effects, identify potential liabilities, and establish a safe therapeutic window. This critical data package is foundational for making informed decisions on clinical development and ultimately bringing a safe and effective therapy to pets in need.

Discover How We Can Help - Request a Consultation

Workflow

Ensuring the safety of novel veterinary therapeutic antibodies requires rigorous in vivo toxicological assessment before clinical application. Our service provides a comprehensive framework to evaluate potential toxicities, determine safe dose ranges, and comply with regulatory requirements for companion animal therapeutics.

Fig 1. Pet Antibody In Vivo Toxicological Evaluation Service Workflow. (Creative Biolabs Original)

Study Design & Regulatory Alignment	Collaborate with clients to define study objectives, species selection (e.g., dogs, cats), and dosing strategies. Align protocols with international veterinary regulatory guidelines.
Animal Model Development	Source healthy, well-characterized animals of the target species. Perform baseline health assessments to establish pre-study reference values.
Dosing & Administration	Administer the therapeutic antibody via clinically relevant routes (IV, SC, IM). Implement multiple dose levels to identify No Observed Adverse Effect Level (NOAEL).
Clinical Observations & Behavioral Monitoring	Continuous monitoring for adverse effects, including clinical signs, body weight changes, and food consumption. Behavioral assessments to detect subtle neurological or systemic toxicities.
Clinical Pathology & Biomarker Analysis	Blood chemistry, hematology, and urinalysis for early detection of organ-specific toxicities. Optional inclusion of immunogenicity, cytokine release, and PK/PD profiling. Detailed histopathology of target organs (liver, kidney, spleen, heart, lymph nodes, injection site).
Data Analysis & Reporting	Comprehensive data interpretation with dose-response correlation. Delivery of toxicology report suitable for regulatory submission.

Why Choose Us?

Species-Specific Expertise
Our studies are tailored to the physiology and immune systems of companion animals, ensuring results that are directly relevant to the intended veterinary species.
Comprehensive Safety Profiling
We assess acute, sub-chronic, and chronic toxicity endpoints, covering hematology, biochemistry, histopathology, and immunogenicity to deliver a complete safety profile.
Integrated Antibody Development Support
From candidate selection to toxicological assessment, we provide seamless integration with our antibody discovery and characterization services, reducing timelines and costs.

FAQs

1. What is the difference between a single-dose and a repeat-dose toxicology study, and which one do I need?

A single-dose (or acute) study assesses the effects of one large dose, which is useful for dose-range finding and initial safety profiling. A repeat-dose (or sub-chronic/chronic) study involves multiple doses over a longer period and is essential for mimicking a clinical treatment regimen to uncover potential cumulative toxicities. The choice depends on your antibody's intended use; we can help you determine the most appropriate strategy during our initial consultation.

2. Can you assist with the development of the bioanalytical assays needed for the study?

Yes, absolutely. Our integrated bioanalytical team is highly experienced in developing and validating custom pharmacokinetic (PK) and antibody-related assays for novel biologics in canine and feline matrices. We can handle this as part of the overall project to ensure seamless sample analysis.

Related Services

Achieve your development milestones faster with our complementary services.

In Vivo Immunogenicity Evaluation

Assess the potential for your therapeutic antibody to elicit an unwanted immune response in the target species, a critical component of any biologics safety package.

Animal Model Customization

We can help you develop or source specific disease models in dogs or cats to evaluate the efficacy of your therapeutic candidate alongside its safety profile.

Partner with Creative Biolabs

Creative Biolabs is dedicated to advancing companion animal health by providing best-in-class preclinical services. Our in vivo toxicological evaluation service provides the critical safety data you need to move your veterinary antibody therapeutic from the bench to the clinic with confidence.

Our team of experts is ready to discuss your specific project needs and how we can help you achieve your goals. Contact our team to learn more about our customized solutions for your pet therapeutic antibody in vivo toxicological evaluation project.

Contact Our Team for More Information and to Discuss Your Project.

Services